date:Dec 18, 2013
In principle, the next step would then be to amend the reference values, said Commission health spokesman Frederic Vincent, adding that EU government officials would begin the process at a meeting in March.
In response, Bayer's CropScience division said it saw no link between imidacloprid and developmental neurotoxicity in humans, and said EFSA had based its concerns on an inconclusive 2012 study that used tests on rat cell cultures.
EFSA itself recognises the limitations of this publication